A groundbreaking paper published this week in Redox Biology reveals the first clearly defined molecular target of molecular hydrogen (H₂), reshaping scientific understanding of how hydrogen exerts its therapeutic effects. The study, co-authored by Dr. Tyler W. LeBaron of the Molecular Hydrogen Institute (MHI), identifies the Rieske iron-sulfur protein (RISP) , a critical component of mitochondrial Complex III, as a primary target of H₂. Read It Here This discovery marks one of the most...

Power Up Altijd en Overal met Moleculair Waterstof (H₂) In een wereld waar vermoeidheid en oxidatieve stress onze prestaties en...

Hoe Moleculaire Waterstof Veroudering Tegen Kan Gaan: Wetenschappelijke Doorbraken en Toepassingen In de zoektocht naar manieren om het...